The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/25182
StudyName: Eligibility Renal Cell Carcinoma NCT00474786
Date of export from the portal: 02.07.2020
Date of Upload / last change: 28.08.2017
License: Creative Commons BY 4.0

----

Description: 
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib; ODM derived from: https://clinicaltrials.gov/show/NCT00474786
